Perioperative Durvalumab for MIBC

Perioperative Durvalumab for MIBC

Discussion panel on oncology research at OncUpdates, featuring medical experts sharing insights on cancer treatment advancements and latest breakthroughs in oncology.

Perioperative Durvalumab for MIBC

06/16/2025

Ep. 5: NIAGARA Trial: Perioperative Durvalumab Enhances DFS in MIBC

Joshua Meeks, MD, PhD

Expert panel discussion on oncology research and recent advancements in cancer treatment.

Perioperative Durvalumab for MIBC

06/16/2025

Ep. 4: The Oncologist’s Role in Counseling Patients With MIBC Through Complex Treatment Decisions

Karine Tawagi, MD

High-level discussion on oncology research and cancer treatment advancements at OncUpdates conference. Experts share insights on innovative therapies and patient care strategies.

Perioperative Durvalumab for MIBC

06/16/2025

Ep. 3: Key Takeaways From the NIAGARA Trial for Patients With MIBC

Neal Shore, MD, FACS

Lecture on cancer treatment innovations discussed among medical professionals.

Perioperative Durvalumab for MIBC

06/16/2025

Ep. 2: Clinical Implications of Circulating Tumor DNA in MIBC

Petros Grivas, MD, PhDJoshua Meeks, MD, PhD

In-depth interview with medical experts discussing latest advancements in cancer treatment and research, focusing on patient care, innovative therapies, and clinical trial updates.

Perioperative Durvalumab for MIBC

06/16/2025

Ep. 1: Current Treatment Strategies for Muscle-Invasive Bladder Cancer

Karine Tawagi, MD

1. Expert oncologists presenting research on NIAGARA trial and perioperative durvalumab treatment for MIBC.

Perioperative Durvalumab for MIBC

06/14/2025

NIAGARA Trial: Perioperative Durvalumab for MIBC (Full Video)

Joshua Meeks, MD, PhDKarine Tawagi, MDNeal Shore, MD, FACSPetros Grivas, MD, PhDRahul Gosain, MD, MBARohit Gosain, MD